Cargando…

Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology

BACKGROUND: Gastric cancer was still one of the commonly diagnosed cancer types and the third-most common cause of cancer-related death in the world. Gentiopicroside, which is extracted from the Gentianella acuta, is commonly used in both traditional treatment and modern clinical care; therefore, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yanxia, Lin, Jiatong, Yi, Weimin, Liu, Qinghua, Cao, Linhui, Yan, Yongcong, Fu, Anqi, Huang, Tingxuan, Lyu, Yingcheng, Huang, Qihui, Wang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700081/
https://www.ncbi.nlm.nih.gov/pubmed/33262572
http://dx.doi.org/10.2147/DDDT.S270757
_version_ 1783616195458498560
author Huang, Yanxia
Lin, Jiatong
Yi, Weimin
Liu, Qinghua
Cao, Linhui
Yan, Yongcong
Fu, Anqi
Huang, Tingxuan
Lyu, Yingcheng
Huang, Qihui
Wang, Jie
author_facet Huang, Yanxia
Lin, Jiatong
Yi, Weimin
Liu, Qinghua
Cao, Linhui
Yan, Yongcong
Fu, Anqi
Huang, Tingxuan
Lyu, Yingcheng
Huang, Qihui
Wang, Jie
author_sort Huang, Yanxia
collection PubMed
description BACKGROUND: Gastric cancer was still one of the commonly diagnosed cancer types and the third-most common cause of cancer-related death in the world. Gentiopicroside, which is extracted from the Gentianella acuta, is commonly used in both traditional treatment and modern clinical care; therefore, its anticancer effects have been attracted more attention. However, the systematic analysis of action mechanism of Gentiopicroside on gastric cancer (GC) has not yet been carried out. AIM: A network pharmacology-based strategy combined with molecular docking studies and in vitro validation was employed to investigate potential targets and molecular mechanism of Gentiopicroside against GC. MATERIALS AND METHODS: Potential targets of Gentiopicroside, as well as related genes of GC, were acquired from public databases. Potential targets, and signaling pathways were determined through bioinformatic analysis, including protein–protein interaction (PPI), the Gene Ontology (GO), and the Kyoto Encyclopedia of Genes and Genomes (KEGG). Subsequently, molecular docking and cell experiments were performed to further verify the above findings. RESULTS: Our findings revealed that the anticancer activity of Gentiopicroside potentially involves 53 putative identified target genes. In addition, GO, KEGG, and network analyses revealed that these targets were associated with cell proliferation, metabolic process, and other physiological processes. Furthermore, we have proved that critical compound affected the expression of CCND1, CCNE1, p-AKT and p-P38 at protein levels. These findings provide an overview of the anticancer action of Gentiopicroside from a network perspective; meanwhile, it might also set an example for future studies of other materials used in traditional Chinese medicine (TCM). CONCLUSION: This study comprehensively illuminated the potential targets and molecular mechanism of Gentiopicroside against GC. It also provided a promising approach to uncover the scientific basis and therapeutic mechanism of TCM treating for disease.
format Online
Article
Text
id pubmed-7700081
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77000812020-11-30 Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology Huang, Yanxia Lin, Jiatong Yi, Weimin Liu, Qinghua Cao, Linhui Yan, Yongcong Fu, Anqi Huang, Tingxuan Lyu, Yingcheng Huang, Qihui Wang, Jie Drug Des Devel Ther Original Research BACKGROUND: Gastric cancer was still one of the commonly diagnosed cancer types and the third-most common cause of cancer-related death in the world. Gentiopicroside, which is extracted from the Gentianella acuta, is commonly used in both traditional treatment and modern clinical care; therefore, its anticancer effects have been attracted more attention. However, the systematic analysis of action mechanism of Gentiopicroside on gastric cancer (GC) has not yet been carried out. AIM: A network pharmacology-based strategy combined with molecular docking studies and in vitro validation was employed to investigate potential targets and molecular mechanism of Gentiopicroside against GC. MATERIALS AND METHODS: Potential targets of Gentiopicroside, as well as related genes of GC, were acquired from public databases. Potential targets, and signaling pathways were determined through bioinformatic analysis, including protein–protein interaction (PPI), the Gene Ontology (GO), and the Kyoto Encyclopedia of Genes and Genomes (KEGG). Subsequently, molecular docking and cell experiments were performed to further verify the above findings. RESULTS: Our findings revealed that the anticancer activity of Gentiopicroside potentially involves 53 putative identified target genes. In addition, GO, KEGG, and network analyses revealed that these targets were associated with cell proliferation, metabolic process, and other physiological processes. Furthermore, we have proved that critical compound affected the expression of CCND1, CCNE1, p-AKT and p-P38 at protein levels. These findings provide an overview of the anticancer action of Gentiopicroside from a network perspective; meanwhile, it might also set an example for future studies of other materials used in traditional Chinese medicine (TCM). CONCLUSION: This study comprehensively illuminated the potential targets and molecular mechanism of Gentiopicroside against GC. It also provided a promising approach to uncover the scientific basis and therapeutic mechanism of TCM treating for disease. Dove 2020-11-23 /pmc/articles/PMC7700081/ /pubmed/33262572 http://dx.doi.org/10.2147/DDDT.S270757 Text en © 2020 Huang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Huang, Yanxia
Lin, Jiatong
Yi, Weimin
Liu, Qinghua
Cao, Linhui
Yan, Yongcong
Fu, Anqi
Huang, Tingxuan
Lyu, Yingcheng
Huang, Qihui
Wang, Jie
Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology
title Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology
title_full Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology
title_fullStr Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology
title_full_unstemmed Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology
title_short Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology
title_sort research on the potential mechanism of gentiopicroside against gastric cancer based on network pharmacology
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700081/
https://www.ncbi.nlm.nih.gov/pubmed/33262572
http://dx.doi.org/10.2147/DDDT.S270757
work_keys_str_mv AT huangyanxia researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology
AT linjiatong researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology
AT yiweimin researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology
AT liuqinghua researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology
AT caolinhui researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology
AT yanyongcong researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology
AT fuanqi researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology
AT huangtingxuan researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology
AT lyuyingcheng researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology
AT huangqihui researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology
AT wangjie researchonthepotentialmechanismofgentiopicrosideagainstgastriccancerbasedonnetworkpharmacology